ID   PPIB_HUMAN              Reviewed;         216 AA.
AC   P23284; A8K534; Q6IBH5; Q9BVK5;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 184.
DE   RecName: Full=Peptidyl-prolyl cis-trans isomerase B;
DE            Short=PPIase B;
DE            EC=5.2.1.8;
DE   AltName: Full=CYP-S1;
DE   AltName: Full=Cyclophilin B;
DE   AltName: Full=Rotamase B;
DE   AltName: Full=S-cyclophilin;
DE            Short=SCYLP;
DE   Flags: Precursor;
GN   Name=PPIB; Synonyms=CYPB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2040592;
RA   Spik G., Haendler B., Delmas O., Mariller C., Chamoux M., Maes P.,
RA   Tartar A., Montreuil J., Stedman K., Kocher H.P., Keller R.,
RA   Hiestand P.C., Movva N.R.;
RT   "A novel secreted cyclophilin-like protein (SCYLP).";
RL   J. Biol. Chem. 266:10735-10738(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Prostate, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 5-216, AND PROTEIN SEQUENCE OF 34-48.
RX   PubMed=2000394; DOI=10.1073/pnas.88.5.1903;
RA   Price E.R., Zydowsky L.D., Jin M., Hunter C.H., McKeon F.D.,
RA   Walsh C.T.;
RT   "Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-
RT   prolyl isomerase with a signal sequence.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:1903-1907(1991).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 10-216.
RX   PubMed=1710767; DOI=10.1128/MCB.11.7.3484;
RA   Hasel K.W., Glass J.R., Godbout M., Sutcliffe J.G.;
RT   "An endoplasmic reticulum-specific cyclophilin.";
RL   Mol. Cell. Biol. 11:3484-3491(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 52-59; 64-76; 91-101; 138-150; 164-172 AND
RP   197-207, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   PROTEIN SEQUENCE OF 72-84 AND 159-165.
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel
RT   protein database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=1530944; DOI=10.1083/jcb.116.1.113;
RA   Arber S., Krause K.-H., Caroni P.;
RT   "S-cyclophilin is retained intracellularly via a unique COOH-terminal
RT   sequence and colocalizes with the calcium storage protein
RT   calreticulin.";
RL   J. Cell Biol. 116:113-125(1992).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [14]
RP   INVOLVEMENT IN OI9.
RX   PubMed=19781681; DOI=10.1016/j.ajhg.2009.09.001;
RA   van Dijk F.S., Nesbitt I.M., Zwikstra E.H., Nikkels P.G.,
RA   Piersma S.R., Fratantoni S.A., Jimenez C.R., Huizer M., Morsman A.C.,
RA   Cobben J.M., van Roij M.H., Elting M.W., Verbeke J.I.,
RA   Wijnaendts L.C., Shaw N.J., Hogler W., McKeown C., Sistermans E.A.,
RA   Dalton A., Meijers-Heijboer H., Pals G.;
RT   "PPIB mutations cause severe osteogenesis imperfecta.";
RL   Am. J. Hum. Genet. 85:521-527(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   INTERACTION WITH DYM.
RX   PubMed=21280149; DOI=10.1002/humu.21413;
RA   Denais C., Dent C.L., Southgate L., Hoyle J., Dafou D., Trembath R.C.,
RA   Machado R.D.;
RT   "Dymeclin, the gene underlying Dyggve-Melchior-Clausen syndrome,
RT   encodes a protein integral to extracellular matrix and Golgi
RT   organization and is associated with protein secretion pathways
RT   critical in bone development.";
RL   Hum. Mutat. 32:231-239(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 39-216.
RX   PubMed=8197205; DOI=10.1073/pnas.91.11.5183;
RA   Mikol V., Kallen J., Walkinshaw M.D.;
RT   "X-ray structure of a cyclophilin B/cyclosporin complex: comparison
RT   with cyclophilin A and delineation of its calcineurin-binding
RT   domain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5183-5186(1994).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.2 ANGSTROMS) OF 34-216 IN COMPLEX WITH CLGN,
RP   MUTAGENESIS OF LYS-129, AND INTERACTION WITH CALR; CANX AND CLGN.
RX   PubMed=20801878; DOI=10.1074/jbc.M110.160101;
RA   Kozlov G., Bastos-Aristizabal S., Maattanen P., Rosenauer A.,
RA   Zheng F., Killikelly A., Trempe J.F., Thomas D.Y., Gehring K.;
RT   "Structural basis of cyclophilin B binding by the
RT   calnexin/calreticulin P-domain.";
RL   J. Biol. Chem. 285:35551-35557(2010).
RN   [21]
RP   VARIANT OI9 ARG-9.
RX   PubMed=20089953; DOI=10.1056/NEJMoa0907705;
RA   Barnes A.M., Carter E.M., Cabral W.A., Weis M., Chang W.,
RA   Makareeva E., Leikin S., Rotimi C.N., Eyre D.R., Raggio C.L.,
RA   Marini J.C.;
RT   "Lack of cyclophilin B in osteogenesis imperfecta with normal collagen
RT   folding.";
RL   N. Engl. J. Med. 362:521-528(2010).
CC   -!- FUNCTION: PPIases accelerate the folding of proteins. It catalyzes
CC       the cis-trans isomerization of proline imidic peptide bonds in
CC       oligopeptides.
CC   -!- CATALYTIC ACTIVITY: Peptidylproline (omega=180) = peptidylproline
CC       (omega=0).
CC   -!- ENZYME REGULATION: Cyclosporin A (CsA) inhibits CYPB.
CC   -!- SUBUNIT: Interacts with DYM. Interacts with CALR, CLGN and CANX.
CC       {ECO:0000269|PubMed:20801878, ECO:0000269|PubMed:21280149}.
CC   -!- INTERACTION:
CC       Q9WMX2:- (xeno); NbExp=7; IntAct=EBI-359252, EBI-9005440;
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-359252, EBI-744695;
CC       P13667:PDIA4; NbExp=3; IntAct=EBI-8771982, EBI-1054653;
CC       P40855:PEX19; NbExp=5; IntAct=EBI-359252, EBI-594747;
CC       O43765:SGTA; NbExp=5; IntAct=EBI-359252, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=3; IntAct=EBI-359252, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-359252, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-359252, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:1530944}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV
CC       (PubMed:17081065). {ECO:0000269|PubMed:17081065}.
CC   -!- DISEASE: Osteogenesis imperfecta 9 (OI9) [MIM:259440]: A form of
CC       osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility
CC       to fractures after minimal trauma. Disease severity ranges from
CC       very mild forms without fractures to intrauterine fractures and
CC       perinatal lethality. Extraskeletal manifestations, which affect a
CC       variable number of patients, are dentinogenesis imperfecta,
CC       hearing loss, and blue sclerae. OI9 is a severe autosomal
CC       recessive form of the disorder. {ECO:0000269|PubMed:19781681,
CC       ECO:0000269|PubMed:20089953}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the cyclophilin-type PPIase family. PPIase
CC       B subfamily. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-9 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA52150.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ppib/";
CC   -!- WEB RESOURCE: Name=Osteogenesis imperfecta variant database;
CC       Note=Peptidyl-prolyl cis-trans isomerase B (PPIB);
CC       URL="http://oi.gene.le.ac.uk/home.php?select_db=PPIB";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M63573; AAA36601.1; -; mRNA.
DR   EMBL; AK291149; BAF83838.1; -; mRNA.
DR   EMBL; CR456829; CAG33110.1; -; mRNA.
DR   EMBL; AY962310; AAX44050.1; -; Genomic_DNA.
DR   EMBL; AC100840; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471082; EAW77669.1; -; Genomic_DNA.
DR   EMBL; BC001125; AAH01125.1; -; mRNA.
DR   EMBL; BC008848; AAH08848.1; -; mRNA.
DR   EMBL; BC020800; AAH20800.1; -; mRNA.
DR   EMBL; BC032138; AAH32138.1; -; mRNA.
DR   EMBL; M60857; AAA52150.1; ALT_INIT; mRNA.
DR   EMBL; M60457; AAA35733.1; -; mRNA.
DR   CCDS; CCDS10191.1; -.
DR   PIR; A39118; CSHUB.
DR   RefSeq; NP_000933.1; NM_000942.4.
DR   UniGene; Hs.434937; -.
DR   PDB; 1CYN; X-ray; 1.85 A; A=39-216.
DR   PDB; 3ICH; X-ray; 1.20 A; A=34-216.
DR   PDB; 3ICI; X-ray; 1.70 A; A/B=34-216.
DR   PDBsum; 1CYN; -.
DR   PDBsum; 3ICH; -.
DR   PDBsum; 3ICI; -.
DR   ProteinModelPortal; P23284; -.
DR   SMR; P23284; -.
DR   BioGrid; 111475; 92.
DR   IntAct; P23284; 32.
DR   MINT; MINT-1142578; -.
DR   STRING; 9606.ENSP00000300026; -.
DR   BindingDB; P23284; -.
DR   ChEMBL; CHEMBL2075; -.
DR   DrugBank; DB00172; L-Proline.
DR   iPTMnet; P23284; -.
DR   PhosphoSitePlus; P23284; -.
DR   SwissPalm; P23284; -.
DR   BioMuta; PPIB; -.
DR   DMDM; 215273869; -.
DR   OGP; P23284; -.
DR   REPRODUCTION-2DPAGE; IPI00646304; -.
DR   SWISS-2DPAGE; P23284; -.
DR   EPD; P23284; -.
DR   MaxQB; P23284; -.
DR   PaxDb; P23284; -.
DR   PeptideAtlas; P23284; -.
DR   PRIDE; P23284; -.
DR   TopDownProteomics; P23284; -.
DR   DNASU; 5479; -.
DR   Ensembl; ENST00000300026; ENSP00000300026; ENSG00000166794.
DR   GeneID; 5479; -.
DR   KEGG; hsa:5479; -.
DR   UCSC; uc002and.4; human.
DR   CTD; 5479; -.
DR   DisGeNET; 5479; -.
DR   GeneCards; PPIB; -.
DR   HGNC; HGNC:9255; PPIB.
DR   HPA; CAB011487; -.
DR   HPA; HPA012720; -.
DR   MalaCards; PPIB; -.
DR   MIM; 123841; gene.
DR   MIM; 259440; phenotype.
DR   neXtProt; NX_P23284; -.
DR   OpenTargets; ENSG00000166794; -.
DR   Orphanet; 216804; Osteogenesis imperfecta type 2.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   Orphanet; 216820; Osteogenesis imperfecta type 4.
DR   PharmGKB; PA33580; -.
DR   eggNOG; KOG0880; Eukaryota.
DR   eggNOG; ENOG410Z0G4; LUCA.
DR   GeneTree; ENSGT00760000119072; -.
DR   HOGENOM; HOG000065981; -.
DR   HOVERGEN; HBG001065; -.
DR   InParanoid; P23284; -.
DR   KO; K03768; -.
DR   OMA; SPAYANE; -.
DR   OrthoDB; EOG091G0BGL; -.
DR   PhylomeDB; P23284; -.
DR   TreeFam; TF354259; -.
DR   BRENDA; 5.2.1.8; 2681.
DR   Reactome; R-HSA-1650814; Collagen biosynthesis and modifying enzymes.
DR   ChiTaRS; PPIB; human.
DR   EvolutionaryTrace; P23284; -.
DR   GeneWiki; PPIB; -.
DR   GenomeRNAi; 5479; -.
DR   PRO; PR:P23284; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000166794; -.
DR   CleanEx; HS_PPIB; -.
DR   Genevisible; P23284; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0034663; C:endoplasmic reticulum chaperone complex; IEA:Ensembl.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0032991; C:macromolecular complex; ISS:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:AgBase.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0003755; F:peptidyl-prolyl cis-trans isomerase activity; ISS:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; ISS:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0070063; F:RNA polymerase binding; IPI:AgBase.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0060348; P:bone development; IMP:UniProtKB.
DR   GO; GO:0061077; P:chaperone-mediated protein folding; IDA:UniProtKB.
DR   GO; GO:0044829; P:positive regulation by host of viral genome replication; IMP:AgBase.
DR   GO; GO:0044794; P:positive regulation by host of viral process; IMP:AgBase.
DR   GO; GO:0040018; P:positive regulation of multicellular organism growth; IMP:UniProtKB.
DR   GO; GO:0000413; P:protein peptidyl-prolyl isomerization; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IMP:UniProtKB.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom.
DR   InterPro; IPR024936; Cyclophilin-type_PPIase.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   PANTHER; PTHR11071; PTHR11071; 1.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Dwarfism;
KW   Endoplasmic reticulum; Glycoprotein; Isomerase;
KW   Osteogenesis imperfecta; Polymorphism; Reference proteome; Rotamase;
KW   Signal.
FT   SIGNAL        1     33       {ECO:0000269|PubMed:2000394}.
FT   CHAIN        34    216       Peptidyl-prolyl cis-trans isomerase B.
FT                                /FTId=PRO_0000025479.
FT   DOMAIN       47    204       PPIase cyclophilin-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00156}.
FT   MOTIF       213    216       Prevents secretion from ER.
FT   MOD_RES     209    209       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24369}.
FT   MOD_RES     209    209       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P24369}.
FT   CARBOHYD    148    148       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT       9      9       M -> R (in OI9; patients have white
FT                                sclerae, normal dentition, no rhizomelia
FT                                or severe deformity of long bones;
FT                                dbSNP:rs137853864).
FT                                {ECO:0000269|PubMed:20089953}.
FT                                /FTId=VAR_063436.
FT   VARIANT      60     60       V -> L (in dbSNP:rs11558595).
FT                                /FTId=VAR_047711.
FT   MUTAGEN     129    129       K->A: Impairs interaction with CLGN and
FT                                CANX. {ECO:0000269|PubMed:20801878}.
FT   CONFLICT      5      5       S -> R (in Ref. 8; AAA52150).
FT                                {ECO:0000305}.
FT   CONFLICT    216    216       E -> D (in Ref. 3; CAG33110).
FT                                {ECO:0000305}.
FT   STRAND       41     52       {ECO:0000244|PDB:3ICH}.
FT   STRAND       55     64       {ECO:0000244|PDB:3ICH}.
FT   TURN         66     68       {ECO:0000244|PDB:3ICH}.
FT   HELIX        70     81       {ECO:0000244|PDB:3ICH}.
FT   TURN         82     84       {ECO:0000244|PDB:3ICH}.
FT   STRAND       95     97       {ECO:0000244|PDB:3ICH}.
FT   TURN         98    100       {ECO:0000244|PDB:3ICH}.
FT   STRAND      101    104       {ECO:0000244|PDB:3ICH}.
FT   TURN        107    109       {ECO:0000244|PDB:3ICH}.
FT   STRAND      110    113       {ECO:0000244|PDB:3ICH}.
FT   STRAND      137    140       {ECO:0000244|PDB:3ICH}.
FT   STRAND      142    144       {ECO:0000244|PDB:1CYN}.
FT   STRAND      152    157       {ECO:0000244|PDB:3ICH}.
FT   HELIX       160    162       {ECO:0000244|PDB:3ICH}.
FT   TURN        163    165       {ECO:0000244|PDB:3ICH}.
FT   STRAND      168    174       {ECO:0000244|PDB:3ICH}.
FT   HELIX       176    183       {ECO:0000244|PDB:3ICH}.
FT   STRAND      193    195       {ECO:0000244|PDB:3ICH}.
FT   STRAND      197    212       {ECO:0000244|PDB:3ICH}.
SQ   SEQUENCE   216 AA;  23743 MW;  2D0410A07AA9E420 CRC64;
     MLRLSERNMK VLLAAALIAG SVFFLLLPGP SAADEKKKGP KVTVKVYFDL RIGDEDVGRV
     IFGLFGKTVP KTVDNFVALA TGEKGFGYKN SKFHRVIKDF MIQGGDFTRG DGTGGKSIYG
     ERFPDENFKL KHYGPGWVSM ANAGKDTNGS QFFITTVKTA WLDGKHVVFG KVLEGMEVVR
     KVESTKTDSR DKPLKDVIIA DCGKIEVEKP FAIAKE
//
